Cipla Q3 net dips 57 pc YoY to Rs 676 cr on lower sales in US

SUMMARY

AI Generated Content
  • Cipla Q3 profit dips 57% due to US sales drop.
  • US Lanreotide supply issues; remediation underway.
  • India business grows 10%; focus on key markets.
AD
AD